Clinical research

Paclitaxel-eluting stents reduce neointimal hyperplasia compared to bare metal stents in saphenous vein grafts: intravascular ultrasonography analysis of the SOS (Stenting of Saphenous Vein Grafts) trial

EuroIntervention 2011;7:948-954. DOI: 10.4244/EIJV7I8A150

Omar Jeroudi
Omar M. Jeroudi1,2, BA; Abdul-Rahman R. Abdel-Karim1,2, MD; Tesfaldet T. Michael1,2, MD; Christopher Lichtenwalter1,2, MD; James A. de Lemos1,2, MD; Owen Obel1,2, MD; Tayo Addo1,2, MD; Michele Roesle1, RN; Donald Haagen1, RCIS; Bavana V. Rangan1, BDS, MPH; Deepa Raghunathan1,2; Monica DaSilva1,2; Bilal Saeed3, MD; Joseph K. Bissett4, MD; Rajesh Sachdeva4, MD; Vassilios V. Voudris5, MD, PhD; Panagiotis Karyofillis5, MD; Biswajit Kar6, MD; James Rossen
1. Veteran Affairs North Texas Healthcare System, Dallas, TX, USA; 2. University of Texas Southwestern Medical Center, Dallas, TX, USA; 3. Department of Internal Medicine, University of Toledo, Toledo, OH, USA; 4. Central Arkansas Veter

Aims: To compare the intravascular ultrasonography (IVUS) findings between saphenous vein grafts (SVG) treated with paclitaxel-eluting stents (PES) vs. bare metal stents

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

saphenous vein graftintravascular ultrasonographypaclitaxel-eluting stentneointimal hyperplasia
Read next article
Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts: incidence, predictors and effect of the type of protection device

Latest news